RAPT Therapeutics Reports First Quarter 2023 Financial Results Portfolio News / By Karina Tin May 11, 2023
Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update Portfolio News / By Karina Tin May 10, 2023
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates Portfolio News / By Karina Tin May 10, 2023
Kallyope Receives $8.2 Million Grant to Identify Novel Interventions for Children and Undernourished Pregnant Women and Mothers Experiencing Environmental Enteric Dysfunction Portfolio News / By Karina Tin May 10, 2023
eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update Portfolio News / By Karina Tin May 9, 2023
NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 Portfolio News / By Karina Tin May 8, 2023
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates Portfolio News / By Karina Tin May 8, 2023
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress Portfolio News / By Karina Tin May 8, 2023
NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data Portfolio News / By Karina Tin May 4, 2023
Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting Portfolio News / By Karina Tin May 3, 2023
